The New England journal of medicine, 2021-05, Vol.384 (21), p.1991-2001
- Bernard, Louis
- Arvieux, Cédric
- Brunschweiler, Benoit
- Touchais, Sophie
- Ansart, Séverine
- Bru, Jean-Pierre
- Oziol, Eric
- Boeri, Cyril
- Gras, Guillaume
- Druon, Jérôme
- Rosset, Philippe
- Senneville, Eric
- Bentayeb, Houcine
- Bouhour, Damien
- Le Moal, Gwenaël
- Michon, Jocelyn
- Aumaître, Hugues
- Forestier, Emmanuel
- Laffosse, Jean-Michel
- Begué, Thierry
- Chirouze, Catherine
- Dauchy, Fréderic-Antoine
- Devaud, Edouard
- Martha, Benoît
- Burgot, Denis
- Boutoille, David
- Stindel, Eric
- Dinh, Aurélien
- Bemer, Pascale
- Giraudeau, Bruno
- Issartel, Bertrand
- Caille, Agnès
2021
Details
- Autor(en) / Beteiligte
- Bernard, Louis
- Arvieux, Cédric
- Brunschweiler, Benoit
- Touchais, Sophie
- Ansart, Séverine
- Bru, Jean-Pierre
- Oziol, Eric
- Boeri, Cyril
- Gras, Guillaume
- Druon, Jérôme
- Rosset, Philippe
- Senneville, Eric
- Bentayeb, Houcine
- Bouhour, Damien
- Le Moal, Gwenaël
- Michon, Jocelyn
- Aumaître, Hugues
- Forestier, Emmanuel
- Laffosse, Jean-Michel
- Begué, Thierry
- Chirouze, Catherine
- Dauchy, Fréderic-Antoine
- Devaud, Edouard
- Martha, Benoît
- Burgot, Denis
- Boutoille, David
- Stindel, Eric
- Dinh, Aurélien
- Bemer, Pascale
- Giraudeau, Bruno
- Issartel, Bertrand
- Caille, Agnès
- Titel
- Antibiotic Therapy for 6 or 12 Weeks for Prosthetic Joint Infection
- Ist Teil von
- The New England journal of medicine, 2021-05, Vol.384 (21), p.1991-2001
- Ort / Verlag
- United States: Massachusetts Medical Society
- Erscheinungsjahr
- 2021
- Link zum Volltext
- Quelle
- Free E-Journal (出版社公開部分のみ）
- Beschreibungen/Notizen
- The appropriate duration of antimicrobial therapy for bacterial prosthetic joint infection is debated. In this open-label, randomized, controlled, noninferiority trial involving 410 patients with prosthetic joint infection at 28 centers across France, antimicrobial therapy for 6 weeks was compared with therapy for 12 weeks and was not found to be noninferior.
- Sprache
- Englisch
- Identifikatoren
- ISSN: 0028-4793eISSN: 1533-4406DOI: 10.1056/NEJMoa2020198Titel-ID: cdi_hal_primary_oai_HAL_hal_03277927v1
- Format
- –
- Schlagworte
- Adverse events, Aged, Anti-Bacterial Agents - administration & dosage, Anti-Bacterial Agents - adverse effects, Antibiotics, Artificial joints, Bacteria, Combined Modality Therapy, Complications and side effects, Dosage and administration, Drug Administration Schedule, Drug therapy, Female, Fistula, Hip Prosthesis - adverse effects, Hospitals, Humans, Infections, Infectious diseases, Intention to Treat Analysis, Joint diseases, Knee Prosthesis - adverse effects, Life Sciences, Male, Medication Adherence - statistics & numerical data, Middle Aged, Pathogens, Patients, Persistent infection, Prostheses, Prosthesis-Related Infections - drug therapy, Prosthesis-Related Infections - surgery, Retention, Santé publique et épidémiologie, Sensitivity analysis, Surgery, Treatment Failure